HomeInsightsStock Comparison

Astonea Labs Ltd vs Bharat Parenterals Ltd Stock Comparison

Astonea Labs Ltd vs Bharat Parenterals Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Astonea Labs Ltd is ₹ 141.25 as of 13 Jun 15:30.
  • The P/E Ratio of Astonea Labs Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Bharat Parenterals Ltd changed from 3.4 on March 2020 to 45 on March 2024 . This represents a CAGR of 67.63% over 5 years.
  • The Market Cap of Astonea Labs Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Bharat Parenterals Ltd changed from ₹ 81.25 crore on March 2020 to ₹ 653.08 crore on March 2024 . This represents a CAGR of 51.72% over 5 years.
  • The revenue of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Bharat Parenterals Ltd for the Mar '25 is ₹ 105.91 crore as compare to the Dec '24 revenue of ₹ 75.2 crore. This represent the growth of 40.84%.
  • The ebitda of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Bharat Parenterals Ltd for the Mar '25 is ₹ 4.16 crore as compare to the Dec '24 ebitda of ₹ 6.59 crore. This represent the decline of -36.87%.
  • The net profit of Astonea Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Bharat Parenterals Ltd changed from ₹ 7.01 crore to ₹ -9.44 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Astonea Labs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Bharat Parenterals Ltd changed from 1.78 % on March 2023 to 2.58 % on March 2024 . This represents a CAGR of 20.39% over 2 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astonea Labs Ltd

  • Astonea Labs Ltd was originally incorporated as 'AHU Laboratories Private Limited', as a private limited company, pursuant to certificate of incorporation dated April 11, 2017.
  • Company changed its name from AHU Laboratories Limited to 'Astonea Labs Private Limited' dated February 26, 2019.
  • Subsequently, the Company converted into 'Astonea Labs Limited', vide fresh Certificate of Incorporation dated January 11, 2024. Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.
  • These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
  • These are used for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.

About Bharat Parenterals Ltd

  • Bharat Parenterals Ltd. was incorporated on Sep.'92 in Gujarat and promoted by Ramesh Desai and Bharat Desai.
  • The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda.
  • It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics. In 2016, Varenyam Healthcare Private Limited was incorporated as wholly owned subsidiary company effective 09 July, 2016.
  • Innoxel Lifesciences was incorporated as wholly owned subsidiary company effective 16th October, 2020.
  • Varenyam Biolifesciences got incorporated as wholly owned subsidiary company effective 28th June, 2022.

Astonea Labs Ltd News Hub

News

BSE SME Astonea Labs inches higher on debut

The scrip was listed at Rs 137.45, a premium of 1.81% compared with the initial public off...

Read more

03 Jun 2025 11:01

Bharat Parenterals Ltd News Hub

News

Board of Bharat Parenterals recommends Final Dividend

Bharat Parenterals announced that the Board of Directors of the Company at its meeting hel...

Read more

12 May 2025 17:16

News

Bharat Parenterals to convene board meeting

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 12 May ...

Read more

06 May 2025 11:30

News

Bharat Parenterals to announce Quarterly Result

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 3 Febru...

Read more

24 Jan 2025 10:28

News

Bharat Parenterals to announce Quarterly Result

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 29 Octo...

Read more

21 Oct 2024 10:22

News

Bharat Parenterals announces board meeting date

Bharat Parenterals will hold a meeting of the Board of Directors of the Company on 8 Augus...

Read more

01 Aug 2024 10:54

News

Bharat Parenterals schedules AGM

Bharat Parenterals announced that the Annual General Meeting (AGM) of the company will be ...

Read more

12 Jun 2024 10:01

SWOT Analysis Of Bharat Parenterals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bharat Parenterals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of null and Bharat Parenterals Ltd

Which company has a larger market capitalization, Astonea Labs Ltd or Bharat Parenterals Ltd?

Market cap of Astonea Labs Ltd is 148 Cr while Market cap of Bharat Parenterals Ltd is 839 Cr

What are the key factors driving the stock performance of Astonea Labs Ltd and Bharat Parenterals Ltd?

The stock performance of Astonea Labs Ltd and Bharat Parenterals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astonea Labs Ltd and Bharat Parenterals Ltd?

As of June 14, 2025, the Astonea Labs Ltd stock price is INR ₹141.25. On the other hand, Bharat Parenterals Ltd stock price is INR ₹1217.6.

How do dividend payouts of Astonea Labs Ltd and Bharat Parenterals Ltd compare?

To compare the dividend payouts of Astonea Labs Ltd and Bharat Parenterals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions